RECOMBINANT NEMATODE NICOTINIC RECEPTOR AND USES

Abstract: The <i>C. elegans unc-63</i> gene is a levamisole resistance locus on chromosome I, which encodes a nicotinic acetylcholine receptor (nAChR) alpha subunit. The derived amino acid sequence of UNC-63 most closely resembles that of UNC-38. Using a gfp: <i>unc-63</i> fusion construct, expression has been detected in muscles (body wall, vulval) and motorneurons of <i>C. elegans</i>. Nuclear injection into <i>Xenopus laevis</i> oocytes of <i>unc-63</i> cDNA together with <i>lev-1</i> and <i>unc-29</i> results in the expression of a robust functional <i>C. elegans</i> heteromeric nAChR. The EC50 for ACh of the expressed receptor (20 mu M) resembles that of native nematode muscle nAChRs. Nicotine and anthelmintic drug levamisole are agonists and mecamylamine is an antagonist of this expressed receptor. When <i>unc-38</i> cDNA is co-injected with cDNAs encoding <i>unc-63</i>, <i>lev-1</i> and <i>unc-29</i> much smaller amplitude agonist-activated currents are observed.

Description: Recombinant Nematode Nicotinic Receptor and Uses Introduction The nematode C. elegans has permitted identification and functional analysis of novel genes expressed m the nervous system (Bargmann, 1998) . This invertebrate animal provides a highly effective genetic model with which to analyse in vivo molecules involved m chemical synaptic transmission (Jorgensen and Nonet 1995; Rand and Nonet 1997; Sattelle 1998) . Neuromuscular cholmergic synapses m C. elegans have been analysed m detail stimulated by the finding that two major postsynaptic components, acetylcholmesterase (AChE, EC 3.1.1.7) and the nicotinic acetylcholme receptor (nAChR), are targets for widely used anthelmmtic drugs . The hydrolytic enzymes AChEs which terminate the actions of ACh are inhibited by carbamates and organophosphates (Massoulie et al 1993) . The nAChRs mediate the fast actions of the neurotransmitter ACh. When ACh binds to an nAChR molecule, the receptor molecule becomes transiently permeable to cations (Na + , K + , Ca 2+ ) . Anthelmmtic drugs such as levamisole, pyrantel and morantel are agonists and open cnannel bloc ers at native nematode muscle nAChRs ' M aτtm 1996) . The stu ie to date of cholmergic anthelmmtic actions on recombinant ACR-16 (=Ce21) homomeric (probably neuronal) nAChRs (Ballivet et al ; Raymond et al 1999) do not mimic the actions observed on native nematode muscle nAChRs . Five polypeptide subunits surround a central ion channel each nAChR molecule, each polypeptide having four transmembrane regions (M1- 4J and a large N-termmal extracellular domain containing residues that form the ACh binding sites (Karlm, 1993, Unwin 1993; Lena _ Changeux 1998) . These subunits are classified as either α subunits, possessing two adjacent cystemes in loop C of the ACh binding site or non-α subunits, with no such adjacent cysteme motif. Radioligand binding studies suggest the possibility of a diversity of nAChRs m C. elegans . For example, using [ 3 H] meta-ammo levamisole, a high saturable affinity binding activity has been observed and is regulated m the course of development, the highest binding activity being detected m larval stages (Lewis et al . 1980) . Several approaches have been undertaken to characterize further nAChR diversity. For example it is possible to isolate mutants obtained by levamisole drug - resistance selection. The major levamisole resistance loci so far isolated, are as follows: lev-1 , lev- 8 , lev-9, lev-10, lev-11 , unc-22, unc-29, unc-38, unc-50 , unc- 63 and unc- 74 . The unc-50 gene encodes a product that may possibly be involved m assembly or transcπptional control of receptor units (Lewis et al 1987; Rand and Nonet 1997) . The lev-11 and unc-22 genes are involved muscle contraction, encoding respectively tropomyosm and twitchm (Williams and Waterston 1994, Beniam et al . 1989) . Among these 11 resistance loci it has been shown that lev-1 and unc-29 both encode non-α subunit (Fleming et al . 1997), whereas unc-38 encodes an α subunit. Molecular characterization of other loci remains to be done A separate genetic screen identified aldicarb resistant mutants. Aldicarb is an AChE inhibitor. This screen resulted m the isolation of 18 new loci, called ric genes (resistant to inhibitor of cholmesterase) and identified molecular components of both pre-synaptic and post-synaptic terminals (Nguyen et al . 1995, Miller et al 1996). Of these loci, π c- 3 appears to be a good candiαate for being a new nAChR subunit . A genetic approach that screens for reduced pharyngeal pumping has identified other mutants and has resulted the isolation of two interacting loc ( eat -2 and eat-18) which also encode candidate nAChR subunits (Raizen et al . 1995) . A further strategy has employed cross - hybridization with either Droεophila nAChR cDNA or previously cloned C. elegans nAChR cDNA. Such techniques have permitted the cloning of three new nAChR subunits acr-2 , acr-3 and acr-16 (Squire et al. 1995, Baylis et al . 1997, Ballivet et al . 1996). Tremen et al (1998) discloses two functionally dependent acetylcholme subunits ( des-2 and deg-3 ) which are encoded a single C . elegans operon. Their linkage a single operon allows their coordinated and stoichiometπc production m the same cells at the same time The nAChR subunits DES-2 and DEG-3 are able to form a heteromeric nAChR composed of two different α subunits. Finally, analysis of the recently (December 1988) completed C. elegans genome sequence shows the presence of 18 new α subunits and 2 new non-α subunits. There is therefore a large family of nAChR subunit genes m C . elegans for which the function remains to be elucidated. Here we present the cloning, by means of a cross- hybπdization approach, of a new α nAChR subunit. We have shown that this new subunit is the product of unc- 63 , a levamisole - resistant gene UNC-63 is expressed body wall muscles of C. elegans and certain motor neurons. This subunit has been co-expressed with UNC-29 and LEV-1 Xenopus oocytes resulting m the first robust heterologous expression of an invertebrate recombinant heteromeric nAChR. The finding that this expressed nAChR containing UNC-63 mimics several of the properties of native nematode muscle receptors offers new opportunities for in vi tro screening of new candidate cholmergic anthelmmtic drugs. Note that the full gencmic sequence of C . elegans does not identify the unc- 63 gene cDNA sequence as such, and there is no information the genomic sequence to indicate that a cDNA sequence from C. elegans could permit function recombinant expression of a major anthelmmtic drug target (namely the nematode nicot ic acetylcholme receptor) which would effectively mimic the natural receptor Figure Legends Figure 1 . Deduced ammo acid sequence of the JTF-38 nAChR α subunit of C . el egans ammo acids are numbered beginning at the first methionine Loops contributing to the ACh binding domain are underlined by plain line The bilayer spanning transmembrane regions TM1-TM4 are underlined by broken lines The horizontal arrow with a broken line indicates the lntracham di-sulfide bond The two adjacent cystemes, typical of all nAChR α-like subunits are shown bold [SEQ ID No 1] Figure 2. Chromosomal localization of the C. elegans tf-38 gene Genetic map position of unc- 63 on chromosome I The YACs Y55F5, Y72D6 and Y72E2 span the unc- 63 locus Figure 3 . Genomic organization of the j tf-38 gene The genomic organization of jtf-38 gene is depicted Boxes indicate exons SL1 refers to the site of attachment of the trans-splice leader SL1 Three subclones, punc-63 1, punc- 63 2 and punc-63 3 of the j tf-38 gene have been tested for tnεir ability to rescue the normal wild type phenotype m unc- 63 mutants Figure 4 . Dendogram showing UNC-63 and related nAChR subunit family members. (A) shows C. elegans m relation to other known nicotmic receptor subunits. (B) shows related subunits with C. elegans . Figure 5. Ammo acid sequence comparison of UNC-63, UNC-38, LEV-1 and UNC-29. Figure 6. Functional expression Xenopus laevis oocytes of UNC-63, UNC-29 and LEV-1 results a functional nAChR at which ACh is an agonist whereas levamisole and nicotine are partial agonists . The agonist action of levamisole is blocked by 10 μM mecamylamine . Materials and methods C. elegans strains and general methods Worm culture, handling followed the technique described by Sulston and Hodgkm (1988) . The wild type C. elegans was the Bristol N2 strain (Brenner, 1974) . Strains containing unc-63 alleles zz37, zz26, b404 were obtained from the Caenorhabdi tis Genetic Center (University of Mmessota) . Sequence analysis Sequence alignment and analysis were performed with the GCG packaging, CLUSTALW and BLAST. Molecular biology Methods published by Sambrook et al . (1989) were used unless otherwise stated. C. elegans genomic was prepared from wild type as described by Koelle. Plasmid DNA was prepared using Tip 100 from Qiagen. Sequencing was performed according to Sanger et al . with fluorescent dye terminator for automated sequencing. Cloning of jtf-38 cDNA A mixed stage cDNA library λgtlO was screened with a probe for unc-38 (Fleming et al . , 1997) at moderate stringency 65°C m 2xSSC, 0.1%SDS. One of the positive clones JTF38 was subjected to further analysis. Sequencing of a 0.6kb EcoRI fragment suggested that the clone contained a genomic insert encoding a nAChR subunit. An antisense oligonucleotide HAB085 was designed which recognized the putative coding sequence from this clone This oligonucleotide was used m a 5' RACE reaction using Marathon cDNA (Clontech) derived from total RNA for mixed stage N2 C. elegans . The reaction was carried out using TaqPlus DNA polymerase mix (Stratagene) . A band of c. 900bp was cloned. Sequencing of the ends demonstrated a sequence identical to the JTF38 clone at the 3' end and a possible nAChR mRNA 5' end at the other An oligonucleotide HAB112 to the 5' end was then used to generate a full length cDNA clone by 3 ' RACE on Marathon cDNA using Expand polymerase mix (Boehπnger Mannheim) . A band of 1.6kb was isolated and cloned into pGEM-T (Promega; to yield the plasmid pHAB385.Thιs insert m this clone was sequenced. The fragment was then excised as a ΪVotI fragment, using sites m the pGEM-T polyl ker and m the Marathon cDNA adaptor and ligated into pMT-3. The orientation of clones was established by PCR and the vector insert junction confirmed by DNA sequencing. A clone of the appropriate structure was named pHAB386. Genetic localization of jtf-38 gene The jtf-38 cDNA was used to probe an ordered grid of yeast artificial chromosome (YAC) clones representing most of the C. el egans genome The jtf-38 cDNA was labeled by random priming with 50 μCi of 32 P dCTP Hybridization has been done following the protocol described by Coulson et al (1995) with 10 6 cpm/ml of hybridization buffer. Mutation detection Total RNA was isolated using Trizol reagent (Life Technologies) from three different unc- 63 allele mutant populations. 2 μg of total RNA was used m each reverse transcription with pdN6 primers, following the manufacturer instructions (Expand reverse transcπptase kit, Boerh ger) . Subsequently 5μl of RT product was used m PCR. We used 4 pairs of primers, deduced from the tf cDNA sequence, and Taq polymerase from Promega. PCR experiments were run for 40 cycles (denaturation at 95°C for 1 mm, annealing at 55°C for 1 mm and elongation at 72°C for 1 mm) . PCR products were cloned into pGEM-T (Promega) and sequenced. Two different clones were sequenced at least for each product. When the mutation was determined the corresponding genomic was sequenced to confirm it. In this case single worm PCR was performed. Briefly 5 mutant worms were picked from the plate and transferred into a lysis buffer containing IX expand buffer from Boenngher and protemase K (0.05 mg/ml) . Worms were denatured by 1 hour incubation at 65°C following by 10 mm incubation at 95 °C . Subsequently 5 μl of lysis worms are used for a PCR using primers deduced from the genomic region showing the mutation. Geπnline transformation Germ line transformation was performed according to the method of Mello and Fire (1995) . Mutant rescue experiment - For rescue experiments 3 different constructs, puπc- 63 . 1 , punc- 63 . 2 and punc- 63 . 3 were generated by means of PCR using the Expand Long Template System (Boenngher) on genomic DNA isolated from N2 worms as described by Koelle (1988) PCR products were cloned into the pGEM-T plasmid. Clones were subsequently checked for the presence of known restriction sites and by sequencing both 5' and 3' extremities. The punc- 63.1 construct contains a 12.5kb insert comprising 4.5kb of 5' region, the all genomic coding region and lkb of 3' untranslated sequence punc- 63 . 2 contains a lOkb insert and differs from punc-63.1 that it has only 2.5kb of genomic sequence upstream of the unc-63 ATG site. The punc-63.3 construct differs from punc-63.2 only by 0.7 kb of 3' untranslated sequence. Germ line transformation was performed by co-mjectmg the test DNA at a concentration of 100-120 ng ml 1 and the plasmid pPD93 65 which contains the GFP gene under the control of the promoter for unc-54 , the myosm heavy chain gene expressed all muscle cells. Transgemc animals are therefore selected by GFP fluorescence m body wall muscle cells and grown on individual plates enabling studies on the phenotype of rescued worms (levamisole sensitivity, normal locomotion and egg laying) . GFP localisation A 10.6 kb fragment was amplified from genomic DNA by means of PCR, using the Expand Long Template system (Boenngher) , with primers designed to contain Sphl (sense primer) and Xmal (forward primer) restriction sites at one end. The fragment includes 4.5 kb of the putative 5' regulatory region and 6kb of genomic coding sequence including exon I through part of exon 7 (encoding the TM3-TM4 extracellular loop) . Th s fragment has been cloned frame into the GFP expressing vector pPD95.70 using the engineered restriction site at both ends of primers. This construction has been designated UNC- 63. :GFP1. The fusion construct UNC-63: :GFP1 at a concentration of 80 mg ml 1 was co- ected with plasmid pRF4 (lOOng μl J into wild type animals. Transgemc animals were selected by their roller phenotype and viewed by fluorescence microscopy (Zeiss Axiovert 35 filtersX) . Functional expression in Xenopus laevis oocytes Ovaries were surgically removed from anaesthetised mature female Xenopus laevis The follicle layers were manually removed from healthy stage V and VI oocytes following a 15 mm incubation with collagenase (type IA, 2 mg ml J a calcium-free version of standard oocyte salme. The composition of SOS was as follows (mM) : NaCl 100, KCl 2, CaCl_ 1 8, MgCl 2 1 and HEPES 5; pH 7.6. In calcium-free salme, the CaCl 2 was replaced by 1.8 mM BaCl 2 The UNC-63-pMT 3 UNC-29- pMT3 , LEV-l-pMT 3 and UNC-38-pMT, expression constructs (Swick et al . , 1992) were isolated from E . coli JM109 using endo- toxm free maxi-prep kits (Qiagen) The nucleus of each oocyte was injected with 20 nl of DNA (0 1 μg μl J The injected oocytes were transferred to incubation medium composed of SOS supplemented with penicillin (100 units ml J , streptomycin (100 μg ml J , gentamycin (50 ug ml -) and 2 5 mM sodium pyruvate and placed at 4°C for 30 mm immediately after injection to enable recovery Oocytes were maintained at 16°C for 2-4 days prior to electrophysiological studies Electrophysiology Oocytes were restrained with entomological pins a Perspex chamber (80 μl volume) with a Sylgard base and perfused continuously (5 ml mm 1 ) with SOS using a gravity- fed system. Membrane currents were measured by the two- electrode voltage-clamp method, using 3M KC1 filled electrodes (resistance = 0.5 - 5 MΩ) and either a Geneclamp amplifier (Axon Instruments) . The oocyte membrane potential was clamped at -100 mV. Signals were digitized by a TL-1 interface (Axon Instruments, U.S.A) . Chemicals Acetylcholme chloride, nicotine, levamisole and mecamylamme were obtained from Sigma. Unless otherwise indicated all other chemicals were obtained from Sigma (UK) . Results Cloning a novel C. elegans nAChR subunit A C. elegans cDNA phage (λ7) library was screened at low stringency using the unc-38 and unc-29 cDNAs as probes Several positive clones were obtained. One positive clone, jtf-38, hybridized specifically at low stringency with unc-38 and was investigated further This positive clone was a partial cDNA but showed 50 % identity at the am o acid level with UNC-38. We then utilised 5 ' RACE to identify tne 5' end of the mRNA and showed that the transcript was transpliced at its 5' end to the RNA splice leader SL1 (Krause a d Hirsh, 1987) The SL1 sequence was found upstream the putative methionme ATG. We then used 3 ' RACE to amplify a full length cDNA clone. This cDNA was designed jtf-38 The jtf-38 clone encodes a nicotinic acetylcholine receptor subunit Sequence analysis of clone jtf-38 revealed an open reading frame of 502 ammo acids. The presumptive deduced protein has a calculated molecular weight of 65 kDa . The sequence shows all the characteristics (cf Galzi and Changeux 1995, Hucho et al 1996) of a new nAChR α subunit We found conserved stretches of ammo acids involved the ACh binding site including loop A, loop B and loop C motifs as well as the ' cys loop' defined by the di-sulfide bridge between cyste es 151 and 165 The two adjacent cystemes, typical of α subunits, are located at am o acid positions 241 and 242. In contrast to UNC-38 (Fleming et al , 1997) and several other C. elegans nicot ic receptor (Mongan et al . , 1999) , the JTF-38 subunit had the typical Y-X-C-C motif the putative loop C of the ACh binding site There are 4 putative transmembrane domains, TM1 (260- 283), TM2 (291-308), TM3 (324-344) and TM4 (464-476) The GCG MOTIFS program identified 3 putative phosphorylation sites all included into the mtracellular loop TM3-TM4 It has been snown that the Torpedo receptor can be phosphorylated by at least three different protein kmases cAMP - dependant kmase (PKA) , protein kmase C (PKC) and a tyros e kmase (TK) The putative sites on unc- 63 are of the PKC (2) and TK (l type Physical and genetic locations of the C. elegans gene identified by the jtf-38 clone We mapped the physical location of this new nAChR gene to YACs Y55F5 and Y72D6, m a cosmid gap, by hybridizing the cloned cDNA to the YAC grid. Thus the jtf-38 gene maps to the center of chromosome I. In this genomic region defined by these two overlapping YACs, lies the levamisole resistant loci unc- 63 . On the other hand previous work has shown that a small YAC Y72E2, which overlaps partially Y55F5 and completely Y72D6, has been injected m the mutant unc- 63 and rescued the levamisole resistance conferring unc- 63 mutant (T. Barnes, personal communication) . We therefore tested whether JTF-38 was unc- 63. We thus determined the entire coding sequence of the corresponding JTF-38 cDNA m three different unc-63 mutant alleles . Several classes of unc- 63 mutations We generated jtf-38 cDNA by RT-PCR from three different mutant alleles of unc- 63 . The x37 mutant allele worms are inactive, slow and extremely resistant to levamisole. For this allele we found a single base transition G:C to A:T at the flanking region of mtron 4. The nitron 4 is not correctly c s-spliced, changing the open reading frame and introducing a stop codon m- frame. The b404 mutant allele has a slight levamisole resistance and a slight uncoordinated movement. We found a deletion (138 nt) m the coding sequence of the M3-M4 mtracellular loop. This deletion kept m phase the two remaining fragments. This deletion removes conserved am o acids and at least the tnree putative phosphorylation sites. Moreover it has been recently showed, m vi vo , that this large mtracellular loop is also involved the localization of nAChR to the active site at the synapse (Williams et al . , 1998) . The x26 mutant allele has normal movement and slight levamisole resistance. We found a G:C to A.T transition changing the cysteme 151 to a Tyrosme. This cysteme part of the loop B involves m the ACh binding site This same mutation has been shown recently to be involved m a human congenital myasthenia syndrome (Milone et al 1998) . The mutant receptor subunit fails to incorporate into the cell surface and is therefore a null mutation Thus the findings for the unc~ 63 mutant alleles provide evidence that the nAChR α subunit cDNA we cloned and unc- 63 are the same gene. In the course of this study the complete genomic sequence of YAC 72E2 covering the unc- 63 locus was determined by the Sanger Center. We therefore compared the unc- 63 genomic and cDNA sequences. The unc-63 gene is composed of 10 exons spanning 7.5 kb. To examine the expression of unc- 63 we performed a Northern blot hybridization and detected a single transcript unc- 63 is expressed in both muscle cells and neurons To address the question of the localization of unc- 63 we monitored its expression by fusing to GFP (Green Fluorescent Protein) (Chalfie et al , 1994) a genomic region comprising 4.5kb of 5' upstream, promoter - containing sequence and the genomic unc- 63 coding region encompassing the first 7 exons. In transgemc animals expressing the UNC-63. :GFP construct, fluorescent signals were observed m all body wall muscle cells and m vulval muscle cells. We also found expression many cells of the nervous system, including motor neurons . These findings are consistent with the unc- 63 mutant defects as mutant worms have defects locomotion and exhibit abnormal egg laying rate. This expression pattern suggests that unc- 63 functions m both muscle and nerve cells of C. elegans . The C. briggsae genome contains a very close relative of the C. elegans unc- 63 gene. The divergence between the two closely related nematode Caenorhabdi tis elegans and Caenorhabdi tis briggsae is as large as between mammals and reptiles (Fitch et al . , 1995) . Many proteins have both a very high level of conservation sequence (Grauso et al 1996) and m function between the two species (Kennedy et al . , 1993; Krause et al . , 1994) . Using PCR and primers deduced from the C. elegans unc- 63 sequence we amplified a nearly full length cDNA. The high homology (95%) between the 2 sequences strongly suggests that we have cloned the C. briggsae unc- 63 homologue. Functional expression of unc- 63 in Xenopus oocytes When cDNAs encoding unc- 63 , lev-1 and unc-29 were injected separately into Xenopus laevis oocytes no evidence of ACh - induced currents was obtained. Pairwise injections of all combinations were similarly unsuccessful m generating ACh - induced currents. However, when all 3 cDNAs were co - injected robust ACh - induced currents (inwardly directed) were detected at a holding potential (E h ) of -lOOmV. The ACh dose - response curve resulted EC 50 value of 20μM. Whereas ACh was a full agonist, levamisole and nicotine showed partial agonist activity on the expressed heterotrimeric UNC- 63, UNC-29, LEV-1 receptor. Mecamylamme (lOμM) was an effective antagonist of the ACh - induced currents 5recorde from the expressed UNC-63, UNC-29, LEV-1 heterotrimeric receptor Thus this robust recombinant heteromeric nAChR resembles respect of ACh, nicotine and levamisole and mecamylamme actions tne native muscle nAChR of Ascans suum muscle (Colquhoun et al . , 1991, 1993). Discussion UNC-63 is a new C. elegans nicotmic acetylcholme receptor (nAChR) α subunit. Its ammo acid sequence shows the vicinal cysteine motif by which such subunits are defined. There are 4 putative transmembrane subunits, a long N- term al region containing sites that show strong conservation with the loops (A-F) which appear to make up ACh binding site (Lena and Changeux 1998) . In the case of UNC-63 the vicinal cystemes are part of a Y-X-C-C motif loop C. Based on its amino acid sequence homology UNC-63 is designated a member of the UNC-38 - like nAChR subunit family, all members of which identified to date are α subunits. Using a gfp fusion construct we have shown that UNC-63 is expressed all body wall muscles, m vulval muscles and m certain motor neurons of C. elegans . UNC-63 and UNC-29 are both strongly expressed body wall muscle of C. elegans (as well as m certain neurons) but nothing is known to date of the expression of LEV-1. This pattern of spatial distribution with a nAChR subunit not being confined to a particular cell or tissue type has now been found for several C. elegans nAChR subunits (see Table 1) , a situation that contrasts strikingly with the situation that so far oD.ains in vertebrates where separate gene families are expressed nerve and muscle. UNC-63 when co-expressed m Xenopus oocytes with UNC-29 and LEV-1 results the most robust functional expression observed to date for a C. elegans recombinant heteromeric nAChR and indeed for any recombinant heteromeric nAChR containing only invertebrate subunits. For example, earlier work on C . elegans recombinant nAChRs using the UNC- 38, UNC-29 and LEV-1 combination did result functional heteromeric receptor but the current amplitudes were much lower than those reported here. Interestingly when we co- expressed UNC-38 with the the other 3 subunits used throughout the present study, this reduced the amplitude of the currents recorded. It is not clear why UNC-38 has this effect. It does have an unusual Y-X-X-C-C motif m loop C of the ACh binding site which may conceivably impair normal ACh - receptor interactions but other factors also remain to be investigated. Certain neuronal nAChR receptors of vertebrates are known to contain 2 distinct α subunits notably α3 and α5. The α5 subunit also has an atypical (A-X- C-C) loop C motif. It may be that UNC-63 and UNC-38 are not normally expressed the same nAChR molecule. The possibility that another non-α subunit is required for UNC-38 to exert its full functional role cannot be discounted. A possible functional role may exist for a 'silencing subunit' eg early m development or at the dauer stage. Changeux and colleagues have suggested a labelling role for nAChRs synapse formation early m development. Alternatively, this effect may simply be the result of mis -assembly of subunits that don't normally belong together Thus of the 11 genes linked to levamisole resistance 4 are now known to be nAChR subunits and one other remains a possible candidate. The gene unc- 63 encoding the new α subunit described here is located on chromosome I of . el egans . The 2 other known members of the UNC-38 - like group of α subunits are located on the same chromosome. None are sufficiently close proximity to be part of a common transcription unit as is the case for other α subunit genes such as ( deg-3 , des-2) Mutants of unc- 63 have proved to be instructive. The mis-sense mutation m allele x37 which results m the insertion of a stop codon gives rise to a phenotype showing very strong resistance to levamisole and slow movement. In tne x26 mutant allele, which appears to have normal movement and only slight levamisole resistance, the cysteme at position 151 is replaced by a tyrosme. The effect of this change the N- erminal region (part of loop B) s to open up the cys loop, an effect similar to that produced by one of the α subunit mutations resulting m a congenital myasthemc syndrome . Conclusion This new α subunit has permitted the first robust functional expression of a nematode nAChR on which levamisole has similar actions to those observed on native nematode muscle nAChRs. This transient expression system and m future a stable cell line containing such recombinant receptors offers the prospect for the first time of rapid high - throughput screening for a new generation of cholmergic anthelmintics and endectocides . Table 1 References Ballivet M, Alliod C, Bertrand S, Bertrand D (1996) Nicot ic acetylcholme receptors m the nematode Caenorhabdi tis elegans . J. Mol . Biol . 258:261-269. Bargmann, C.I. (1998) Neurobiology of the Caenorhabdi tis elegans genome. Science 282: 2028-2033. Baylis, H.A., Matsuda, K. , Squire, M.D., Fleming, J.T., Harvey, R., Darlison, M.G., Barnard, E.A., and Sattelle, D.B. (1997) ACR-3, a Caenorhabdi tis elegans nicot ic acetylcholme receptor subunit: molecular cloning and functional expression. Receptors and Channels 5: 149-158 Benian, G.M., Kiff, J.E., Neckelmann, N., Moerman, D.G. and Waterston, R.H. (1989) Sequence of an unusually large protein implicated m regulation of myosm activity C. elegans . Nature 342 : 45-50. Chalfie, M. , Tu, Y , Euskirchen, G. , Ward, W.W. and Prasher, D.C. (1994) Green fluorescent protein as a marker for gene expression. Science 263: 802-805. Colquhoun, L., Holden-Dye, L. and Walker, R.J. (1991) The pnarmacology of cholmoreceptors on the somatic muscle cells of the parasitic nematode Ascaris suum . J. Exp . Biol . 158, 509-530. Colquhoun, L., Holden-Dye, L. and Walker, R.J. (1993) The action of nicot ic receptor specific toxins on the somatic muscle cells of the parasitic nematode Ascaris suum . Mol . Neuropharmacol . 3, 11-16. Coulson, A.R., Huynh, C, Kosono, Y. and Shownkeen, R. (1995) The physical map of The Caenorhabdi tis elegans genome. In Caenorhabdi tis elegans . Modern Biological Analysis of an Organism, pp 534-549, Academic Press. Fitch, D.H.A, Bugaj-Gaweda, B. and Emmons, S.W. (1995) 18S ribosomal RNA gene phylogeny for some Rhabditidae related to Caenorhabdi tis elegans . Mol . Biol . Evol . 12: 346-358. Fleming, J.T., Squire, M.D., Barnes, T.M., Tornoe, C, Matsuda, K. , Ahnn, J., Fire, A., Sulston, J.E., Barnard, E.A., Sattelle, D.B. and Lewis, J.A. (1997) J. Neurosci . 17: 5843-5857. Galzi, J.L., and Changeux, J.P., (1994) Neurotransmitter- gated ion channels as unconventional allosteric proteins. Curr. Opin . Struc . Biol 4: 554-565. Grauso, M., Culetto, E., Berge, J.B., Toutant , J.P. and Arpagaus, M. (1996) Sequence comparison of ace-1 the gene encoding acetylcholmesterase of class A, m the two nematodes Caenorhabdi tis elegans and Caenorhabdi tis briggsae . DNA sequence 6: 217-227 Harrow, I.D. and Gration, K.A.F. (1985) Mode of action of the anthelmmtics morantel, pyrantel, and levamisole on muscle cell membrane of the nematode Ascaris suum . Pesti c . Sci . 16: 662-672. Hucho, F., Tsetlin, V.I. and Machold, J. (1996) The emerging three dimensional structure of a receptor : The nicot ic acetylcholme receptor. Eur. J. Bioche . 239: 539-557. Jorgensen, E.M. and Nonet, M.L. (1995) Neuromuscular junctions m the nematode Caenorhabdi tis elegans . Seminars m Devel . Biol . 6: 207-220. Karlin A (1993) Structure of nicotmic acetylcholme receptors. Curr. Opin . Neurobiol . 3:299-309. Kennedy, B.P., Aamodt, E.J., Allen, F.L, Chung, M.A., Heschl, M.F.P. and McGhee, J.D. (1993) The gut esterase gene (ges -1 ) from the nematodes Caenorhabdi tis elegans and Caenorhabdi tis briggsae . J. Mol . Biol . 229: 890-908 Krause, M., Harrison, S.Q., Xu, L., Chen, L. and Fire, A. (1994) Elements regulating cell and stage specific expression of the C. elegans MyoD family homolog hlh -1 . Devel . Biol . 166: 133-148. Krause, M. and Hirsh, D. (1987) A trans-spliced leader sequence on actin mRNA m C. el egans . Cell 49: 753-761. Lena, C. and Changeux, J.P. (1998) . Allosteπc nicot ic receptors, human pathologies. J. Physiol . (Paris) , 92: 63 - "7 4. Lewis, J.A., Wu, C.H., Levme, J.H., and Berg, H., (1980) Levamisole-resistant mutants of the nematode Caenorhabdi tis elegans appear to lack pharmacological acetylcholme receptors. J. Neurosci . 5: 967-928. Lewis, J.A., Elmer, J.S., Skimming, J., McLafferty, S , Fleming, J. and McGee, T. (1987) Cholmergic receptor mutants of the nematode Caenorhabdi tis elegans . J. Neurosci . 7: 3059- 3071. Martin, R.J., Valkanov, M.A., Dale, M.E., Robertson, A. . and Murray, I. (1996) Electrophysiology of Ascaris muscle and anti-nematodal drug action. Parasi tol . 113: S137 - S156. Massoulie, J. , Pezzementi, L., Bon, S., Kr ci, E. and Vallette, F.M. (1993) Molecular and cellular biology of chol esterases . Prog. Neurobiol . 41: 31-91. Mongan, N.P., Baylis, H.A. , Adcock, C, Smith, G. R. , Sansom, M.S. P. and Sattelle, D.B. (1998) An extensive and diverse nicotmic acetylcholme receptor α subunit gene family Caenorhabdi tis elegans . Receptors and Channels 6: 213-228. Milone M, Wang H-L, Ohno K, Prince R, Fukudome T, Shen X-M, Brengman JM, Griggs RC, Sine SM, Engel AG. (1998) Mode switching kinetics produced by a naturally occurmg mutation the cytoplasmic loop of the human acetylcholme receptor ε subunit. Neuron 20-575-588. Miller, K.G., Alfonso, A , Nguyhen, M., Crowell, J.A., Johnson, CD. and Rand, J.B. (1996) A genetic selection for Caenorhabdi tis elegans synapt c transmission mutants. Proc . Nazl . Acad . Sci . 93: 12593-12598. Nguyen, M., Alfonso, A., Johnson, CD. and Rand, J.B. (1995) Caenorhabdi tis elegans mutants resistant to inhibitors of acetylcholmesterase. Genetics 140: 527-535. Fleming, J.T., Squire, M.D., Barnes, T.M., Tornøe, C.T., Matsuda, K. , Sulston, J.E., Barnard, E.A., Sattelle, D.B., and Lewis, J.T. (1997) Caenorhabdi tis elegans levamisole resistance genes l ev- 1 , unc-29 and unc-38 encode functional nicotmic acetylcholme receptor subunits. J. Neurosci . 17: 5843-5857. Rand JB and Nonet ML (1997) "Synaptic transmission" in C elegans II (eds Riddle DL Blumenthal T Meyer B J and Priess JR) pp. 611-643 Cold Spring Harbor Laboratory Press. Raizen, D.M., Lee, R.Y.N. and Avery, L. (1995) Interacting genes required for pharyngeal excitation by motor neuron MC Caenorhabdi ti s elegans . Genetics 141: 1365-1382. Raymond, V., Mongan, N.P. and Sattelle, D.B. (1999) Actions of cholmergic anthelmmtics and ivermectm on recombinant homomeric nicot ic acetylcholme receptors, chicken 7 and Caenorhabdi tis elegans ACR-16. Bri t . J. Pharm . (submitted) . Sattelle, D.B.. (1998) . Genetic, genomic and functional studies on the nicotmic acetylcholme receptor gene family of Caenorhabdi tis elegans . J. Physiol . 18S: 513P. Unw , N. (1993) Nicotmic acetylcholme receptor at 9A resolution. J. Mol . Biol . 229: 1101-1124. Thompson, J.D. Gibson, T.J. Plewmak, F., Jeanmougm, F. and Higgms, D.G. (1997) The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided bu quality analysis tools. Nucleic Acids Res . 25- 4876-4882. Treinin, M. et al (1988) Two functionally dependent acetylcholme subunits are encoded m a single C. elegans operon. P.N.A.S. 95 15492-15495. Williams, B.D. and Waterston, R.H. (1994) Genes critical for muscle development function m Caenorhabdi tis elegans identified through lethal mutations. J " . Cell Biol . 124: 475- 490.

Claims: Claims 1. A recombinant nematode nicotmic receptor which mimics the properties of a natural nicotmic receptor of a nematode m respect to response to anthelmmtic compounds and/or drugs. 2. An isolated DNA segment obtainable from C . elegans unc- 63 which encodes an α nAChR subunit, which subunit is a functional nematode nicot ic receptor. 3. A DNA segment according to claim 2 which is a cDNA having the amino acid sequence of SEQ ID No . 1 or a mutant or derivative thereof; wherein the mutant or derivative is a functional analogue of the sequence by virtue of conservative am o acid deletion, addition or substitution. 4. A vector containing the DNA segment of claim 2 or 3. 5 A host transformed by the vector of claim 4. 6. A host containing a transgene encoding a recombinant receptor according to claim 1. 7. A host according to claim 5 or 6 which is a cell line. 8. A method of producing a recombinant receptor according to claim 1 comprising culturmg a host according to claims 5, 6 or 7 transformed with a vector according to claim 4 under conditions for the expression of said receptor . 9 A method according to claim 8 m which the C.elegrans unc-63 gene which encodes α nAChR subunit is coexpressed with one or more nAChr subunits . 10. Use of a receptor according to claim 1 an assay for screening compounds for anthelmmtic activity. 11 Use of DNA according to claim 2 or 3 m an assay for screening compounds for anthelmmtic activity. 12. Use of a vector according to claim 4 m an assay for screening compounds for anthelmmtic activity. 13. Use of a host according to claim 5 or 6 or 7 an assay for screening compounds for anthelmmtic activity. 14 A method of screening for anthelmmtic compounds which includes the steps of: l) exposing a recombinant receptor according to claim 1 to one or more compounds to be screened for anthelmmtic activity; li ) selecting a compound or compounds which interact with sa d receptor; and in) characterising said selected compounds as anthelmmtic compounds . 15 Anthelmmtic compounds selected by the method of claim 14. 16 A method of parasitic nematode control a plant or animal or human, which comprising the administration of a compound or a pharmaceutical composition containing a compound according to claim 15. 7. A recombinant nematode nicotinic receptor according to claim 1 which mimics the response of the natural receptor to the anthelmintic drug Levamisole.

Inventors: BAYLIS HOWARD, CULETTO EMMANUEL, SATTELLE DAVID, BAYLIS, HOWARD, CULETTO, EMMANUEL, SATTELLE, DAVID
Applicants: BABRAHAM INST, BAYLIS HOWARD, CULETTO EMMANUEL, SATTELLE DAVID, BABRAHAM INSTITUTE, BAYLIS, HOWARD, CULETTO, EMMANUEL, SATTELLE, DAVID
Application year: 2000
Main classification: C12N15
IPC codes: A01K67, A61K45, A61P33, C07K14, C12N5, C12N15, C12P21, C12Q1, G01N33